- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
BioCryst Pharmaceuticals Inc+ Add to Watchlist
BCRX:US12.0200 USD 0.1700 1.39%
As of 13:05:30 ET on 10/24/2014.
Company Profile for BioCryst Pharmaceuticals Inc (BCRX)
BioCryst Pharmaceuticals, Inc. designs, optimizes and develops small-molecule novel pharmaceuticals that block key enzymes involved in infectious diseases, inflammatory diseases & cancer. The Company has late-stage compounds in development & continues to discover additional compounds & to progress them to meet the unmet medical needs of patients and physicians.
BioCryst Pharmaceuticals Inc
Key Executives for BioCryst Pharmaceuticals Inc (BCRX)
|Jon P StonehousePresident/CEO||Thomas R Staab II "Tom"Senior VP/CFO/Acctg Ofcr|
|William P SheridanSenior VP/Chief Medical Ofcr||Yarlagadda S BabuSenior VP: Drug Discovery|
|Alane P BarnesVP/Secretary/General Counsel|